Mayer Brown advised Novartis AG and Novartis Capital Corporation in connection with a $5 billion four-tranche SEC-registered bond offering.
Citigroup Global Markets Inc., HSBC Securities (USA) Inc., Morgan Stanley & Co. LLC and MUFG Securities Americas Inc., Barclays Capital Inc., Deutsche Bank Securities Inc. and Mizuho Securities USA LLC acted as joint book-running managers.
Novartis is a leading global medicines company that uses innovative science and digital technologies to create transformative treatments in areas of great medical need.
The Mayer Brown team was led by Banking & Finance partner Bernd Bohr (Picture; London), supported by Banking & Finance associate Whitney Joseph (London), Tax Transactions & Consulting partner Jared Goldberger and associates Juan Lopez Valek and Brennan Young (all New York) and Financial Services Regulatory & Enforcement partner Jeffrey P. Taft (Washington DC).
Law Firms: Mayer Brown;
Clients: Novartis AG;